Related references
Note: Only part of the references are listed.Serum levels of inflammation-related markers and metabolites predict response to neoadjuvant chemotherapy with and without bevacizumab in breast cancers
Marianne E. Nome et al.
INTERNATIONAL JOURNAL OF CANCER (2020)
Pentraxin 3 in Cardiovascular Disease
Giuseppe Ristagno et al.
FRONTIERS IN IMMUNOLOGY (2019)
The Long Pentraxin PTX3 as a Link Between Innate Immunity, Tissue Remodeling, and Cancer
Andrea Doni et al.
FRONTIERS IN IMMUNOLOGY (2019)
Early Changes in Cardiovascular Biomarkers with Contemporary Thoracic Radiation Therapy for Breast Cancer, Lung Cancer, and Lymphoma
Biniyam G. Demissei et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2019)
Anthracycline-induced cardiotoxicity: A multicenter randomised trial comparing two strategies for guiding prevention with enalapril: The International CardioOncology Society-one trial
Daniela Cardinale et al.
EUROPEAN JOURNAL OF CANCER (2018)
Contemporary Role of Echocardiography for Clinical Decision Making in Patients During and After Cancer Therapy
Jennifer Liu et al.
JACC-CARDIOVASCULAR IMAGING (2018)
Cardiotoxic effects of anthracycline-based therapy: what is the evidence and what are the potential harms?
Bennett E. Levis et al.
LANCET ONCOLOGY (2017)
Neurohormonal Blockade and Circulating Cardiovascular Biomarkers During Anthracycline Therapy in Breast Cancer Patients: Results From the PRADA (Prevention of Cardiac Dysfunction During Adjuvant Breast Cancer Therapy) Study
Geeta Gulati et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2017)
Cancer Therapy-Related Cardiac Dysfunction and Heart Failure Part 1: Definitions, Pathophysiology, Risk Factors, and Imaging
Michelle W. Bloom et al.
CIRCULATION-HEART FAILURE (2016)
Prevention of cardiac dysfunction during adjuvant breast cancer therapy (PRADA): a 2 x 2 factorial, randomized, placebo-controlled, double-blind clinical trial of candesartan and metoprolol
Geeta Gulati et al.
EUROPEAN HEART JOURNAL (2016)
2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines
Jose Luis Zamorano et al.
EUROPEAN HEART JOURNAL (2016)
Angiotensin II-Receptor Inhibition With Candesartan to Prevent Trastuzumab-Related Cardiotoxic Effects in Patients With Early Breast Cancer A Randomized Clinical Trial
Annelies H. Boekhout et al.
JAMA ONCOLOGY (2016)
Early Detection of Anthracycline Cardiotoxicity and Improvement With Heart Failure Therapy
Daniela Cardinale et al.
CIRCULATION (2015)
Use of biomarkers for the assessment of chemotherapy-induced cardiac toxicity
Eric S. Christenson et al.
CLINICAL BIOCHEMISTRY (2015)
Early Increases in Multiple Biomarkers Predict Subsequent Cardiotoxicity in Patients With Breast Cancer Treated With Doxorubicin, Taxanes, and Trastuzumab
Bonnie Ky et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2014)
Enalapril and Carvedilol for Preventing Chemotherapy-Induced Left Ventricular Systolic Dysfunction in Patients With Malignant Hemopathies
Xavier Bosch et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2013)
Pentraxin-3 in chronic heart failure: the CORONA and GISSI-HF trials
Roberto Latini et al.
EUROPEAN JOURNAL OF HEART FAILURE (2012)
Early Detection and Prediction of Cardiotoxicity in Chemotherapy-Treated Patients
Heloisa Sawaya et al.
AMERICAN JOURNAL OF CARDIOLOGY (2011)
An Integrated View of Humoral Innate Immunity: Pentraxins as a Paradigm
Barbara Bottazzi et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 28 (2010)
Determination of physiological plasma pentraxin 3 (PTX3) levels in healthy populations
Kazumi Yamasaki et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2009)
The humoral pattern recognition receptor PTX3 is stored in neutrophil granules and localizes in extracellular traps
Sebastien Jaillon et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2007)
Prevention of high-dose chemotherapy-induced cardiotoxicity in high-risk patients by angiotensin-converting enzyme inhibition
Daniela Cardinale et al.
CIRCULATION (2006)
Prognostic value of troponin I in cardiac risk stratification of cancer patients undergoing high-dose chemotherapy
D Cardinale et al.
CIRCULATION (2004)
Prognostic significance of the long pentraxin PTX3 in acute myocardial infarction
R Latini et al.
CIRCULATION (2004)
Effects of valsartan on circulating brain natriuretic peptide and norepinephrine in symptomatic chronic heart failure - The Valsartan Heart Failure Trial (Val-HeFT)
R Latini et al.
CIRCULATION (2002)
Plasma brain natriuretic peptide concentration: Impact of age and gender
MM Redfield et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2002)
Left ventricular dysfunction predicted by early troponin I release after high-dose chemotherapy
D Cardinale et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2000)
Share Paper
